XML 28 R8.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Millions
Total
Preferred stock, exchanged for shares of common stock
Class A Warrants
Class B Warrants
Class C Warrants
Preferred Stock
Preferred Stock
Preferred stock, exchanged for shares of common stock
Common Stock
Common Stock
Preferred stock, exchanged for shares of common stock
Additional Paid-in Capital
Additional Paid-in Capital
Class A Warrants
Additional Paid-in Capital
Class B Warrants
Additional Paid-in Capital
Class C Warrants
Retained Earnings (Accumulated Deficit)
Accumulated Other Comprehensive Income
Treasury Stock
Non-controlling Interest
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                  
Beginning balance (in shares)               9,772,793                  
Preferred stock, shares outstanding, beginning balance (in shares) at Dec. 31, 2019           5,563,458                      
Beginning balance at Dec. 31, 2019 $ 4,401         $ 1,631   $ 0   $ 16,973       $ (14,220) $ 12 $ (32) $ 37
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                  
Share-based compensation (in shares)               7,753                  
Share-based compensation (14)                 (14)              
Dividends on preferred stock (22)                 (22)              
Hedging activity 33                           33    
Net income (loss) (9,734)                         (9,734)      
Exchange of preferred stock into common stock (in shares)             (100)   1                
Exchange of preferred stock into common stock   $ 0                              
Purchase of shares for company benefit plans (2)                             (2)  
Release of shares for company benefit plans 34                             34  
Comprehensive loss attributable to noncontrolling interests (16)                               (16)
Divestiture of underlying assets (21)                               (21)
Preferred stock, shares outstanding, end of period (in shares) at Dec. 31, 2020           5,563,358                      
Ending balance (in shares) at Dec. 31, 2020               9,780,547                  
Ending balance at Dec. 31, 2020 (5,341)         $ 1,631   $ 0   16,937       (23,954) 45 0 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                  
Beginning balance (in shares)               9,780,547                  
Share-based compensation (in shares)               67                  
Share-based compensation 3                 3              
Hedging activity 3                           3    
Net income (loss) 5,383                         5,383      
Comprehensive loss attributable to noncontrolling interests 0                                
Cancellation of Predecessor Equity (in shares)           (5,563,358)   (9,780,614)                  
Cancellation of Predecessor equity (48)         $ (1,631)       (16,940)       18,571 (48)    
Issuance of Successor common stock (in shares)               97,907,081                  
Issuance of Successor common stock 3,331             $ 1   3,330              
Issuance of warrants     $ 93 $ 94 $ 68           $ 93 $ 94 $ 68        
Preferred stock, shares outstanding, end of period (in shares) at Feb. 09, 2021           0                      
Ending balance (in shares) at Feb. 09, 2021               97,907,081                  
Ending balance at Feb. 09, 2021 3,586         $ 0   $ 1   3,585       0 0 0 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                  
Beginning balance (in shares)               97,907,081                  
Share-based compensation (in shares)               248,487                  
Share-based compensation 21                 21              
Issuance of common stock for Acquisition (in shares)               18,709,399                  
Issuance of common stock for Acquisition 1,237                 1,237              
Issuance of common stock for warrant exercise (in shares)               188,292                  
Issuance of common stock for warrant exercise 2                 2              
Issuance of reserved common stock and warrants (in shares)               864,090                  
Issuance of reserved common stock and warrants 0                                
Hedging activity 0                                
Net income (loss) 945                         945      
Comprehensive loss attributable to noncontrolling interests 0                                
Dividends on common stock (120)                         (120)      
Preferred stock, shares outstanding, end of period (in shares) at Dec. 31, 2021           0                      
Ending balance (in shares) at Dec. 31, 2021               117,917,349                  
Ending balance at Dec. 31, 2021 5,671         $ 0   $ 1   4,845       825 0 0 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                  
Beginning balance (in shares)               117,917,349                  
Share-based compensation (in shares)               174,740                  
Share-based compensation 21                 21              
Issuance of common stock for Acquisition (in shares)               9,442,185                  
Issuance of common stock for Acquisition 764                 764              
Issuance of common stock for warrant exchange offer (in shares)               16,305,984                  
Issuance of common stock for warrant exchange offer 67                 67              
Issuance of common stock for warrant exercise (in shares)               2,102,244                  
Issuance of common stock for warrant exercise 27                 27              
Issuance of reserved common stock and warrants (in shares)               439,370                  
Issuance of reserved common stock and warrants $ 0                                
Repurchase and retirement of common stock (in shares) (11,700,000)             (11,666,778)                  
Repurchase and retirement of common stock $ (1,073)                         (1,073)      
Hedging activity 0                                
Net income (loss) 4,936                         4,936      
Comprehensive loss attributable to noncontrolling interests 0                                
Dividends on common stock (1,222)                         (1,222)      
Deemed dividend on warrants (67)                         (67)      
Preferred stock, shares outstanding, end of period (in shares) at Dec. 31, 2022           0                      
Ending balance (in shares) at Dec. 31, 2022               134,715,094                  
Ending balance at Dec. 31, 2022 $ 9,124         $ 0   $ 1   $ 5,724       $ 3,399 $ 0 $ 0 $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                  
Beginning balance (in shares)               134,715,094